Parenteral ascorbic acid as a key for regulating microcirculation in critically ill

Critical Care Medicine

Volumn 36, Issue 8, 2008, Pages 2466-2468

  Biesalski, Hans Konrad ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Ascorbic acid; Endothelial dysfunction; Endothelial nitric oxide synthase; Nicotinamide adenine dinucleotide phosphate oxidase; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; ASCORBIC ACID; CAROTENOID; DOCOSAHEXAENOIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ANTIOXIDANT;

ANTIOXIDANT ACTIVITY; ARTIFICIAL VENTILATION; CAPILLARY FLOW; CELL TRANSPORT; CIRCULATION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; EDITORIAL; ENDOTHELIUM CELL; FLUID RESUSCITATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INJECTION; INNATE IMMUNITY; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK; RISK REDUCTION; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; VASODILATATION; VITAMIN SUPPLEMENTATION; ANIMAL; DRUG EFFECT; INTENSIVE CARE; METABOLISM; MOUSE; NOTE; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CRITICAL CARE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERGLYCEMIA; MICE; MICROCIRCULATION; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; SEPSIS;

EID: 49949111683     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181810494     Document Type: Editorial

References (18)

1. Berger MM: Antioxidant micronutrients in major trauma and burns: Evidence and practice. Nutr Clin Pract 2006; 21:438-449
2. McGregor GP, Biesalski HK: Rationale and impact of vitamin C in clinical nutrition. Curr Opin Clin Nutr Metab Care 2006; 9:697-703
3. Long CL, Maull KI, Krishnan RS, et al: Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003; 109:144-148
4. Nathens AB, Neff MJ, Jurkovich GJ, et al: Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236:814-822
5. Biesalski HK, McGregor GP: Antioxidant therapy in critical care - Is the microcirculation the primary target? Crit Care Med 2007; 35(9 Suppl):S577-S583
6. May JM: How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 2000; 28:1421-1429
7. Tyml K, Li F, Wilson J: Septic impairment of capillary blood flow requires NADPH oxidase but not NOS and is rapidly reversed by ascorbate through an eNOS-dependant mechanism. Crit Care Med 2008; 36:2355-2362
8. Li JM, Shah AM: Mechanism of endothelial cell NADPH oxidase activation by angiotensin. II. Role of the p47phox subunit. J Biol Chem 2003; 278:12094-12100
9. Landmesser U, Dikalov S, Price SR, et al: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003; 111:1201-1209
10. Seno T, Inoue N, Matsui K, et al: Functional expression of sodium-dependent vitamin C transporter 2 in human endothelial cells. J Vasc Res 2004; 41:345-351
11. Rumsey SC, Kwon O, Xu GW: Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem 1997; 272: 18982-18989
12. Schorah, CJ, Downing C, Piripitsi A, et al: Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996; 63:760-765
13. Lunec J, Blake DR: The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA). Free Radic Res Commun 1985; 1:31-39
14. Nualart FJ, Rivas CI, Montecinos VP, et al: Recycling of vitamin C by a bystander effect. J Biol Chem 2003; 278:10128-10133
15. Lehr HA, Germann G, McGregor GP, et al: Consensus meeting on "Relevance of parenteral vitamin C in acute endothelial dependent pathophysiological conditions (EDPC)". Eur J Med Res 2006; 11:516-526
16. Mullan BA, Ennis CN, Fee HJ, et al: Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia. Am J Physiol Heart Circ Physiol 2004; 287: H1262-H1268
17. Mü hlhöfer A, Mrosek S, Schlegel B, et al: High-dose intravenous vitamin C is not associated with an increase of pro-oxidative biomarkers. Eur J Clin Nutr 2004; 58: 1151-1158
18. Tanaka H, Matsuda T, Miyagantani Y, et al: Reduction of resuscitation fluid volumes inseverely burned patients using ascorbic acid administration: A randomized, prospective study. Arch Surg 2000; 135:326-331 19. Mullan BA, Ennis CN, Fee HJ, et al: Pretreatment with intravenous ascorbic acid preserves endothelial function during acute hyperglycaemia (R1). Clin Exp Pharmacol Physiol 2005; 32:340-345